Litigation Details for Teijin Limited v. Prinston Pharmaceutical Inc. (D. Del. 2014)
✉ Email this page to a colleague
Teijin Limited v. Prinston Pharmaceutical Inc. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-07-01 |
| Court | District Court, D. Delaware | Date Terminated | 2015-11-13 |
| Cause | 35:0145 | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | |
| Patents | 6,225,474; 8,372,872 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Teijin Limited v. Prinston Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Teijin Limited v. Prinston Pharmaceutical Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-07-01 | 1 | for infringement of U.S. Patent No. 6,225,474 (“the ’474 patent” or “patent-in-suit”). This action arises…date of the ’520 patent is March 25, 2019. INFRINGEMENT OF U.S. PATENT NO. 6,225,474 28. Plaintiffs … the ’474 patent is attached as Exhibit A. ll. Teijin Ltd. is the owner of the ’474 patent. Teijin Pharma…certification with respect to U.S. Patent No. 5,614,520 (“the ’520 patent”) pursuant to 21 U.S.C. § 505@)…’474 patent, including any applicable exclusivities or extensions, would infringe the ’474 patent under | External link to document | |
| 2015-10-15 | 37 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,372,872 B2; . (Noreika, Maryellen… 13 November 2015 1:14-cv-00854 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
